# Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention

> **NCT01505790** · PHASE3 · COMPLETED · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 187 (actual)

## Conditions studied

- Acute Coronary Syndromes

## Interventions

- **DRUG:** PRASUGREL
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT01505790
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 187 (ACTUAL)
- **Last updated:** 2012-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01505790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01505790, "Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01505790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*